[1]
Mashayekhi, P., Noruzinia, M. and Khodaverdi, S. 2022. Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study. International Journal of Reproductive BioMedicine (IJRM). 20, 10 (Nov. 2022), 861–872. DOI:https://doi.org/10.18502/ijrm.v20i10.12270.